Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Mannino

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Pharmaceutical Statistics|April 5, 2008
Consequences of dichotomizationValerii Fedorov, Frank Mannino, Rongmei Zhang
Plos One|March 3, 2020
Equiprobable discrete models of site-specific substitution rates underestimate the extent of rate variabilityFrank Mannino, Sadie Wisotsky, Sergei L Kosakovsky Pond, et al.
Journal of Clinical Pharmacology|December 28, 2020
Effect of Renal and Hepatic Impairment on the Pharmacokinetics of Temsavir, the Active Moiety of FostemsavirMindy Magee, Jill Slater, Frank Mannino, et al.
HIV Medicine|November 13, 2022
Fostemsavir and ethinyl estradiol drug interaction: Clinical recommendations for co-administrationNneka Nwokolo, Elana Post, A Savannah Mageau, et al.
Antimicrobial Agents and Chemotherapy|April 25, 2023
Efficacy of Intravenously Administered Gepotidacin in Cynomolgus Macaques following a Francisella tularensis Inhalational ChallengeCharles Jakielaszek, Jamese J Hilliard, Frank Mannino, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2024
Efficacy of therapeutically administered gepotidacin in a rabbit model of inhalational anthraxJamese J Hilliard, Charles Jakielaszek, Frank Mannino, et al.
Science Translational Medicine|June 1, 2022
Gepotidacin is efficacious in a nonhuman primate model of pneumonic plagueCharles Jakielaszek, Mohammad Hossain, Lian Qian, et al.
Antimicrobial Agents and Chemotherapy|May 3, 2022
Week 96 Genotypic and Phenotypic Results of the Fostemsavir Phase 3 BRIGHTE Study in Heavily Treatment-Experienced Adults Living with Multidrug-Resistant HIV-1Margaret Gartland, Pedro Cahn, Edwin DeJesus, et al.
The Lancet. Haematology|December 22, 2015
Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trialUwe Platzbecker, Raymond S M Wong, Amit Verma, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Pharmaceutical Statistics|April 5, 2008
Consequences of dichotomizationValerii Fedorov, Frank Mannino, Rongmei Zhang
Plos One|March 3, 2020
Equiprobable discrete models of site-specific substitution rates underestimate the extent of rate variabilityFrank Mannino, Sadie Wisotsky, Sergei L Kosakovsky Pond, et al.
Journal of Clinical Pharmacology|December 28, 2020
Effect of Renal and Hepatic Impairment on the Pharmacokinetics of Temsavir, the Active Moiety of FostemsavirMindy Magee, Jill Slater, Frank Mannino, et al.
HIV Medicine|November 13, 2022
Fostemsavir and ethinyl estradiol drug interaction: Clinical recommendations for co-administrationNneka Nwokolo, Elana Post, A Savannah Mageau, et al.
Antimicrobial Agents and Chemotherapy|April 25, 2023
Efficacy of Intravenously Administered Gepotidacin in Cynomolgus Macaques following a Francisella tularensis Inhalational ChallengeCharles Jakielaszek, Jamese J Hilliard, Frank Mannino, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2024
Efficacy of therapeutically administered gepotidacin in a rabbit model of inhalational anthraxJamese J Hilliard, Charles Jakielaszek, Frank Mannino, et al.
Science Translational Medicine|June 1, 2022
Gepotidacin is efficacious in a nonhuman primate model of pneumonic plagueCharles Jakielaszek, Mohammad Hossain, Lian Qian, et al.
Antimicrobial Agents and Chemotherapy|May 3, 2022
Week 96 Genotypic and Phenotypic Results of the Fostemsavir Phase 3 BRIGHTE Study in Heavily Treatment-Experienced Adults Living with Multidrug-Resistant HIV-1Margaret Gartland, Pedro Cahn, Edwin DeJesus, et al.
The Lancet. Haematology|December 22, 2015
Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trialUwe Platzbecker, Raymond S M Wong, Amit Verma, et al.
Pageof 1